O Medo da COVID-19 e Fatores Relacionados que Afetam a Autoeficácia do Aleitamento Materno durante a Pandemia

Objetivo: Este estudo teve como objetivo determinar os níveis de autoeficácia do aleitamento materno durante a pandemia, compará-los de acordo com várias características e examinar a relação entre o medo da COVID-19 e a autoeficácia do aleitamento materno. Método: Os dados do presente estudo descritivo e transversal foram coletados por meio de uma pesquisa baseada na web com 392 mães, entre junho e agosto de 2021. Os instrumentos de coleta de dados foram o Formulário de Dados de Introdução, o Formulário Breve de Escala de Autoeficácia do Aleitamento Materno e a Escala de wMedo da COVID-19. Resultado: A pontuação média de autoeficácia do aleitamento materno foi de 56,18 ± 8,24, enquanto a pontuação média de escala de medo da COVID-19 foi de 21,77 ± 6,14. Ter um grande medo da COVID-19, amamentar com mais frequência nesse período e suspeitar da COVID-19 afetou positivamente as pontuações de autoeficácia do aleitamento materno, enquanto concluir o ensino fundamental teve um efeito negativo na mesma autoeficácia.Conclusão: Foi afetado positivamente a autoeficácia do aleitamento materno daqueles que tinham medo da COVID-19, que amamentavam com mais frequência durante a pandemia e que tinham um nível educacional mais elevado.Objective: This study aimed to determine the breastfeeding self-efficacy levels of mothers during the pandemic period, to compare them according to various characteristics, and to examine the relationship between the fear of COVID-19 and breastfeeding self-efficacy. Method: The data of this descriptive and cross-sectional were collected through a web-based survey of 392 mothers between June and August 2021. The data collection tools were the Introductory Data Form, the Breast-feeding Self-Efficacy Scale-Short Form, and the Fear of COVID-19 Scale. Results: The mean score for breastfeeding self-efficacy was found to be 56.18 ± 8.24, while the mean score for the Fear of COVID-19 scale was 21.77 ± 6.14. Having a high fear of COVID-19, breastfeeding more frequently in this period, and suspecting that they had COVID-19 affected the breastfeeding self-efficacy scores positively, whereas graduating from primary school had a negative effect on self-efficacy. Conclusion: The breastfeeding self-efficacy of mothers who were fearful of COVID-19, who breastfed more frequently during the pandemic, and who had a higher education level were positively affected.Objetivo: Este estudio tuvo como objetivo determinar los niveles de autoeficacia de lactancia materna durante la pandemia, compararlos según diversas características y examinar la relación entre el miedo al COVID-19 y la autoeficacia de lactancia materna. Método: Los datos del presente estudio descriptivo y transversal se recopilaron a través de una encuesta basada en la web con 392 madres, entre junio y agosto de 2021. Las herramientas de recopilación de datos fueron el Formulario de Datos de Introducción, el Formulario Breve de Escala de Autoeficacia de Lactancia Materna y la Escala de Miedo al COVID-19. Resultado: La puntuación media de autoeficacia de lactancia materna fue de 56,18 ± 8,24, mientras que la puntuación media de escala de miedo al COVID-19 fue de 21,77 ± 6,14. Tener un gran miedo al COVID-19, amamantar con mayor frecuencia en este período, y sospechar de COVID-19 afectó positivamente los puntajes de autoeficacia de lactancia materna, mientras que graduarse de la escuela primaria tuvo un efecto negativo en la misma autoeficacia. Conclusión: Conclusión: Se afectó positivamente la autoeficacia de lactancia materna de aquellas que tenían miedo al COVID-19, que amamantaron con mayor frecuencia durante la pandemia y que tenían un mayor nivel educativo

Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey

Objective: Congenital adrenal hyperplasia (CAH) is the most common form of primary adrenal insufficiency in children. Neonatal screening for CAH is effective in detecting the salt-wasting (SW) form and in reducing mortality. In this study, our aim was to estimate the incidence of CAH in Turkey and to assess the characteristics and efficacy of the adopted newborn CAH screening strategy. Methods: A pilot newborn CAH screening study was carried out under the authority of the Turkish Directorate of Public Health. Newborn babies of ≥32 gestational weeks and ≥1500 gr birth weight from four cities, born between March 27-September 15, 2017 were included in the study. Screening protocol included one sample two-tier testing. In the first step, 17α-hydroxyprogesterone (17-OHP) was measured by fluoroimmunoassay in dried blood spots (DBS) obtained at 3-5 days of life. The cases with positive initial screening were tested by steroid profiling in DBS using a liquid chromatography-tandem mass spectrometry method to measure 17-OHP, 21-deoxycortisol (21-S), cortisol (F), 11-deoxycortisol and androstenedione as a second-tier test. The babies with a steroid ratio (21-S+17-OHP)/F of ≥0.5 were referred to pediatric endocrinology clinics for diagnostic assessment. Results: 38,935 infants were tested, 2265 (5.82%) required second-tier testing and 212 (0.54%) were referred for clinical assessment, six of whom were diagnosed with CAH (four males, two females). Four cases were identified as SW 21-hydroxylase deficiency (21-OHD) (two males, two females). One male baby had simple virilizing 21-OHD and one male baby had 11-OHD CAH. The incidence of classical 21-OHD in the screened population was 1:7,787. Conclusion: The incidence of CAH due to classical 21-OHD is higher in Turkey compared to previous reports. We, therefore, suggest that CAH be added to the newborn screening panel in Turkey. The use of steroid profiling as a second-tier test was found to improve the efficacy of the screening and reduce the number of false-positives.PubMedWoSScopu

Growth curves for Turkish Girls with Turner Syndrome: Results of the Turkish Turner Syndrome Study Group

OBJECTIVE: Children with Turner syndrome (TS) have a specific growth pattern that is quite different from that of healthy children. Many countries have population-specific growth charts for TS. Considering national and ethnic differences, we undertook this multicenter collaborative study to construct growth charts and reference values for height, weight and body mass index (BMI) from 3 years of age to adulthood for spontaneous growth of Turkish girls with TS. METHODS: Cross-sectional height and weight data of 842 patients with TS, younger than 18 years of age and before starting any therapy, were evaluated. RESULTS: The data were processed to calculate the 3rd, 10th, 25th, 50th, 75th, 90th and 97th percentile values for defined ages and to construct growth curves for height-for-age, weight-for-age and BMI-for-age of girls with TS. The growth pattern of TS girls in this series resembled the growth pattern of TS girls in other reports, but there were differences in height between our series and the others. CONCLUSION: This study provides disease-specific growth charts for Turkish girls with TS. These disease-specific national growth charts will serve to improve the evaluation of growth and its management with growth-promoting therapeutic agents in TS patients